Globus Medical, Inc. Class A Common Stock (GMED)
EBITDA
$945.76M
TTM · Period ending: · USD
GMED EBITDA
Latest reported$945.76Mperiod ending
Latest reported$945.76Mperiod ending
GMED TTM EBITDA ($115.80M → $945.76M)
TTM EBITDA
High-resolution chart · PNG
GMED ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 945,758,000 | |
| 879,885,000 | |
| 817,090,000 | |
| 717,981,000 | |
| 618,804,000 | |
| 551,739,000 | |
| 472,421,000 | |
| 424,254,000 | |
| 394,652,000 | |
| 355,528,000 | |
| 346,583,000 | |
| 328,196,000 | |
| 318,483,000 | |
| 314,828,000 | |
| 304,503,000 | |
| 268,690,000 | |
| 263,110,000 | |
| 258,387,000 | |
| 264,725,000 | |
| 299,223,000 | |
| 295,752,000 | |
| 206,667,000 | |
| 178,346,000 | |
| 162,638,000 | |
| 152,881,000 | |
| 218,924,000 | |
| 225,272,000 | |
| 218,965,000 | |
| 210,175,000 | |
| 211,431,000 | |
| 216,781,000 | |
| 218,414,000 | |
| 215,841,000 | |
| 207,413,000 | |
| 205,387,000 | |
| 200,903,000 | |
| 200,344,000 | |
| 196,438,000 | |
| 192,993,000 | |
| 202,687,000 | |
| 203,465,000 | |
| 201,807,000 | |
| 195,585,000 | |
| 174,260,000 | |
| 167,575,000 | |
| 161,547,000 | |
| 155,561,000 | |
| 156,214,000 | |
| 150,684,000 | |
| 147,817,000 | |
| 144,125,000 | |
| 135,487,000 | |
| 132,728,000 | |
| 132,459,000 | |
| 131,314,000 | |
| 128,311,000 | |
| 127,464,000 | |
| 121,394,000 | |
| 115,795,000 |